Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

cbdMD (YCBD) Gains from Investment Securities: 2016-2025

Historic Gains from Investment Securities for cbdMD (YCBD) over the last 5 years, with Sep 2025 value amounting to $1.7 million.

  • cbdMD's Gains from Investment Securities was N/A to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.8 million, marking a year-over-year change of. This contributed to the annual value of $599,521 for FY2025, which is 73.17% up from last year.
  • According to the latest figures from Q3 2025, cbdMD's Gains from Investment Securities is $1.7 million, which was up 47.99% from $1.2 million recorded in Q4 2024.
  • In the past 5 years, cbdMD's Gains from Investment Securities registered a high of $8.9 million during Q1 2021, and its lowest value of -$3.8 million during Q3 2021.
  • Moreover, its 3-year median value for Gains from Investment Securities was -$31,867 (2023), whereas its average is $384,140.
  • Its Gains from Investment Securities has fluctuated over the past 5 years, first plummeted by 14,732.74% in 2021, then spiked by 1,769.70% in 2024.
  • Over the past 5 years, cbdMD's Gains from Investment Securities (Quarterly) stood at $660,417 in 2021, then crashed by 109.24% to -$61,000 in 2022, then fell by 14.35% to -$69,752 in 2023, then surged by 1,769.70% to $1.2 million in 2024, then reached $1.7 million in 2025.
  • Its last three reported values are $1.7 million in Q3 2025, $1.2 million for Q4 2024, and -$4,828 during Q1 2024.